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A B S T R A C T
Background and Purpose: Aortoiliac (AI) lesions (both dilatative and occlusive) can occur in kidney allograft
recipients. The correct timing of vascular imaging and treatment is controversial. Aim of the present paper is
to report our experience.
Methods: between January 2010 and December 2012, 106 patients included in our waiting list for kidney
transplant underwent computed tomography (CT) angiogram to study AI axis. In 21 cases an AI lesion was
identiﬁed before transplant. In 3 cases surgery was mandatory before kidney transplant, and in 18 cases
lesions were treated simultaneously with kidney transplantation.
Main ﬁndings: AI pathology distribution was as follows: 15 iliac stenoses treated with thrombo-
endarterectomy (TEA), 2 Leriche syndrome and 1 aortic aneurism treatedwith an aortobisiliac bypass (AI-BP),
and 3 aneurysms treated with endovascular aortic repair (EVAR). In two cases a postoperative hematoma
occurred. In one case occlusion of a stent-graft branch was treated with a femoro-femoral crossover bypass
and transplant was then performed on the contralateral iliac axis. Perioperative mortality was 0%, and graft
survival rate was 100% at 1 year in all cases.
Conclusions: A CT angiogram is useful in order to detect AI lesions and to be able to evaluate the best
treatment option for the kidney transplantation and the correct timing for additional vascular surgery. The
EVAR procedure should be safe, and does not compromise anastomosis success and graft survival, with less
postoperative complications than open surgery.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Cardiovascular diseases are the main cause of death in patients
awaiting renal transplantation. 1,2 The constantly increasing number
of aortoiliac (AI) lesions (dilatative or occlusive) in kidney allograft
recipients seems to be a result of three main factors: increased
recipient age, uremia and commonly present dysmetabolism. 3–5 An
increasing number of abdominal aortic aneurysms occur in renal
failure patients because of strong association between atherosclerosis
and chronic kidney disease. 4,6 Additional major risk factors for
cardiovascular diseases include hypertension, hypercholesterolemia,
diabetes, and smoking. 7 AI lesions (both dilatative and occlusive)
could inﬂuence the results of kidney transplantation and increase
technical difﬁculties during surgery. 1 An increasing number of
centers have suggested the possibility to perform the renal transplan-
tation and the vascular reconstruction in combination, 5 even though
traditionally the performance of either one of these procedures was
considered a contraindication to the other. In the present study we
report our experience.
2. Patients and Methods
2.1. Patient evaluation and inclusion criteria
Between January 2010 and December 2012, 194 patients were
evaluated for kidney transplantation eligibility, of whom 156 (80%;
M:F 3:2, mean age 55±15 y) were included in our waiting list
(exclusion criteria were mainly high cardiovascular risk, neoplasms,
comorbidities and age). Patients aged over 50 years [n =71 (45.5%),
M:F 2:1; mean age 59±7y] or younger with 2 or more risk factors
between diabetes, hypertension, smoke, dyslipidemia or dialysis
conducted for more than 5 years [n =35 (22.4%), M:F 3:1; mean age
46±9y] underwent vascular assessment including a full examination
by ankle brachial pressure index (ABI), Doppler assessment and
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thorax–abdomen computed tomography (CT) angiogram in order to
evaluate AI axis before transplantation.
Inclusion criteria for this study were detection of aneurysm with
diameter >50mm or stenotic AI lesions type C or D according to TASC
classiﬁcation (Transatlantic Intersociety Consensus).
All enrolled patients underwent a kidney transplantation within
the study period.
2.2. Patient characteristics
Twenty-one patients (18.9%;M:F 2:1;mean age 54±9y)were enrolled
prospectively in this study. AI stenotic lesions Type C or D according
to TASC classiﬁcation were found in 17 cases (81%); these included
2 cases of iliac bilateral sub-occlusive lesion (Leriche syndrome –
TASC Type D). Patients were not symptomatic for critical limb
ischemia (CLI) in all cases.
Aortic aneurysms were discovered in 4 cases (19%): AI aneurysms
(class IIB according to Schumacher) in 3 (19%) and 1 multi-level
aortic aneurysm (class B according to Estrera – thoracic aneurysm of
diameter 45mm, considered not eligible for surgical treatment at the
moment).
2.3. Surgical procedures (Fig. 1)
2.3.1. Endovascular aortic repair (EVAR) and kidney transplant
In 3 cases aneurysms were corrected with EVAR before kidney trans-
plant (mean time 13±9 months). All procedure were performed in a
theater equippedwith amovable radiolucent surgical table combined
with a digital angiographic system using a ceiling-suspended C-arm
(isocentric mobile C-arm, Siemens, Munich, Germany), under general
anesthesia by a cardiovascular surgeon in close collaboration with an
interventional radiologist.
Fig. 1. Surgical treatment for vascular disease.
In all cases the iliac axis was preserved from the dilatative lesion so
that the common iliac artery could be used as a “landing zone”. This
procedure allowed to preserve external iliac artery for the renal artery
anastomosis (Fig. 2). All patients were prepared and draped also
for potential conversion in laparotomy. Surgical exposure included
the common femoral artery bilaterally in all cases. Once we gained
remote access, administration of 1250 IUheparin (Epsoclar®, Biologici
Italia Laboratories, Novate Milanese, Italy) was followed by insertion
of the stent-graft (SG) System (Excluder, W.L. Gore & associates,
Flagstaff, AZ, USA). A calibrated angiographic pigtail catheter (Cook
Inc., Bloomington, IN, USA) was placed in the aorta, followed by
digital subtraction angiography (DSA) to conﬁrm the beginning of
the aneurysm and to determine the ﬁnal landing zone. Devices were
then positioned with conﬁrmatory DSA before deployment to enable
precise positioning. Dimensions of the SG were determined on the
basis of contrast-enhanced spiral CT images and angiographic images.
Once deployed, SG were assessed with DSA to identify the presence
of endoleak. An inﬂatable balloon was eventually used to model the
SG to the aortic wall.
Fig. 2. CT angiogram of kidney transplant in aortic-bisiliac EVAR for AAA.
Kidney transplant was performed with a standard technique.
After procurement, all kidneys from heart-beating donors were
ﬂushed with 1 liter of preservation solution (Celsior, Genzyme
Sanoﬁ, Cambridge, MA, USA) and then preserved with static cold
storage. Kidneys were prepared at bench and then employed for
transplantation. In all cases an inverted J-shaped “hockey stick”
incision was performed, the graft was placed in the retroperitoneal
iliac fossa and vascular anastomoseswere performed between kidney
vessels and external iliac vessels just at the conﬂuence of external–
internal iliac vessels. Ureteral implantation was performed using
Lich–Gregoir technique with a double-J ureteral stent.
2.3.2. Aortobisiliac bypass (AI-BP) and kidney transplant
In 4 cases an AI-BP was performed (Fig. 3) (Leriche syndrome n=2,
aortic aneurysm n=2) simultaneously with kidney transplantation.
The standard operative procedure consisted of a midline laparotomy.
Administration of 1250 IU heparin (Epsoclar®, Biologici Italia Labo-
ratories, Novate Milanese, Italy) was followed by aorta clamping. An
arteriotomywas performed and the proximal end of an appropriately-
sized silver knitted polyester vascular bifurcated prosthesis (Intergard
Silver, Maquet, Rastatt, Germany) was sutured. Distal anastomosis
was performed onto a suitable segment of the external iliac artery.
Fig. 3. MRI angiogram of kidney transplant in aortic-bifemoral bypass for Leriche’s
syndrome.
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The renal graft (after standard kidney procurement and preservation)
was placed as usual in the retroperitoneal iliac fossa after right-colon
mobilization and vascular anastomoses were performed between
kidney vessels and external iliac vein and prosthetic arterial branch.
Ureteral implantation was performed using Lich–Gregoir technique
with a double-J ureteral stent.
2.3.3. Iliac thromboendarterectomy (TEA) and kidney transplant
In 15 cases iliac stenoses were treated with TEA (Fig. 4). 8 In all cases
TEA was performed during transplantation surgery. In all cases an
inverted J-shaped “hockey stick” incision was performed.
Once we exposed iliac vessels through retroperitoneal access,
administration of 1250 IU heparin (Epsoclar®, Biologici Italia Lab-
oratories, Novate Milanese, Italy) was followed by clamp of iliac
arteries. The common iliac artery was opened via a longitudinal
arteriotomy and endoarterectomy was performed to remove the
plaque. Arteriotomy was generally extended distally to the external
iliac artery to remove plaque from the proximal part of the vessel.
Fig. 4. Endarterectomy of iliac vessel during kidney transplant.
The renal graft (after standard kidney procurement and preser-
vation) was placed in the retroperitoneal iliac fossa and venous
anastomose was performed between kidney vein and external iliac
vein. Reconstruction of iliac artery and bifurcation was completed
in 9 cases (60%) with direct suture between iliac artery and graft
renal artery and in 6 cases (40%) using a patch (bovine pericardium).
Ureteral implantation was performed with Lich–Gregoir technique
with a double-J ureteral stent.
2.4. Intra and post-operative therapy
All patients received short-term prophylactic antibiotic therapy (gen-
erally, vancomycin 2 g) and heparinization intraoperatively. Twelve
hours after vascular procedure, sodium enoxaparin (Clexane, Sanoﬁ-
aventis, Milan, Italy) and clopidogrel 75mg (Plavix, Sanoﬁ Pharma/
Bristol-Myers Squibb, Paris, France) were given to all patients.
Enoxaparin was given to all patients for 1 month postoperatively
and the dose was adjusted based on glomerular ﬁltration rate (GFR)
estimated with the Cockroft–Gault formula (2000 IU with GFR
<30mL/min, 4,000 IU with GFR 30mL/min) and substituted with
acetylsalicylate 100mg (Cardioaspirin, Bayer, Basel, Switzerland) in
association with clopidogrel thereafter.
During the transplantation procedure all patients received an in-
duction treatment consisting of monoclonal antibodies (basiliximab
[Simulect, Novartis, Basel, Switzerland]) before graft reperfusion and
at the fourth post-operative day. The same maintenance therapy, in-
cluding tacrolimus (Prograf, Astellas Pharma, Tokyo, Japan),mycophe-
nolic acid (Myfortic, Novartis Pharma, Basel, Switzerland), together
with steroids, was given to all recipients. The dose of tacrolimus was
adjusted so as to maintain blood trough levels of 10–15ng/mL during
the ﬁrst month, and 8–12ng/mL thereafter. Mycophenolic acid was
given at the highest tolerated dose (1440mg/day), mainly based on
hematologic toxicity and gastrointestinal side effects. Steroids were
tapered to 4mg/day at 45 postoperative days.
2.5. Follow up
For the purpose of the present study, vascular assessment including
physical examination and Doppler was performed after the vascular
procedure at 1, 3, 6, and 12 months. Creatinine after transplantation
was assessed at discharge, 6 and 12 postoperativemonths. All patients
presented at least 1 year of follow up.
2.6. Statistical analysis
Data were collected prospectively in a secure database hosted by our
research center. Data are presented asmean ± standarddeviation (SD).
Tests for association in 2×2 tables were performed with Pearson’s
chi square with Yates’ correction or with Student’s t-test for paired
data.
3. Results
3.1. EVAR
In all cases the SG was placed successfully, no procedure was aborted
because of access difﬁculty, and no conversion to standard open
repair was necessary. Intraoperative mortality was not observed. The
mean duration of the procedure was 90±12 minutes. The average
total amount of contrast was 118±50mL. Mean hospitalization was
5±3 days. Overall 30-day operative mortality was 0%, endoleak
rate was 0%. Transplantation was performed at 16±7 months
after EVAR.
In 1 case (33%) we observed acute limb ischemia due to SG throm-
bosis (left endoprosthesis branch) at 5 months postoperatively.
In this case a femorofemoral cross-over bypass was performed
employing a silver knitted polyester vascular prosthesis (Intergard
Silver, Maquet, Rastatt, Germany). Anastomoses were made to the
common femoral arteries and the graft was tunnelled superﬁcially,
anterior to the rectus sheath. Duration of surgery was 125min.
12 months after that procedure the patient underwent kidney
transplantation successfully. Vascular anastomoses were performed
on right iliac axis.
3.2. AI-BP and TEA
Intraoperative mortality was not observed. The mean duration of
surgery was 130±35 minutes for AI-BP and 25±6 minutes for TEA.
In two cases a post-operative hematoma after iliac TEA occurred;
reoperation was not necessary. Overall 30-day operative mortality
was 0%. Patency at 12 months postoperatively was 100%.
3.3. Kidney transplantation and graft survival
In all cases graft function was immediate. Intraoperative mortality
was not observed. Primary non-function (PNF) or delayed graft
function (DGF) were not observed. At discharge, mean serum
creatinine level was 1.3±0.4mg/dL. One year post-operative, graft
survival rate was 100%. At 6 months mean serum creatinine level was
1.2±0.5mg/dL, and at 12 months it was 1.1±0.4mg/dL.
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4. Discussion
The increasing number of AI lesions in kidney allograft recipient
seems associated with increasing recipient age, dysmetabolism
and terminal uremic condition. 4 This underlines the need for a
speciﬁc and sensitive diagnostic protocol for the AI district. The
diagnosis of AI occlusive disease often requires a high index of
suspicion because symptoms are usually absent and ﬂow-limiting
disease may exist despite a normal clinical examination. Femoral
pulse palpation provides little information regarding hemodynam-
ically signiﬁcant AI lesions. 9 Angiography, or more recently digital
subtraction angiography, is the gold standard for diagnosis of AI
occlusive disease. 10 However, angiography is expensive, invasive
and, given the low incidence of AI disease, probably not cost-
effective. 11 The utility of AI duplex ultrasonography in the screening
for AI disease has been controversial. Duplex ultrasonography has a
sensitivity of 91% and speciﬁcity of 93% for the detection of stenosis
compared to angiography. 12,13 CT angiography was found to have
96% sensitivity and 97% speciﬁcity in diagnosing hemodynamically
signiﬁcant lesions of the AI region and lower extremity compared to
angiography; 14 however, short stenoses may fail to be demonstrated
by CT scans. 15 Tsivian et al. consider the possibility to perform
annual ultrasonographic vascular screening evaluation, speciﬁcally
targeted at the AI axis, in all patients on the waiting list and,
if pathology is suspected, to refer to advanced imaging such as
CT angiography. 16 There are only few large studies on AI surgery
and kidney transplantation; this lack of data probably is due on the
one hand to the surgical procedure requiring a highly experienced
vascular surgeon, and on the other hand to patients with serious
vasculopathy being excluded from transplantation waiting lists. 12
Atheroma and/or calciﬁcation can cause technical difﬁculty in
graft arterial anastomoses, insufﬁcient blood perfusion of the graft,
exacerbation of lower extremities ischemia and other cardiovascular
complications during perioperative period. 17 Some recipients require
pre-transplantation vascular surgery, others require arterial repair
during transplantation because the arteries cannot be clamped or a
satisfactory arterial anastomosis cannot be performed. When plaque
compromises suturing quality or anastomosis permeability, a plaque
excision with intimal ﬁxation is necessary to allow correct arterial
anastomosis. 18,19
The TASC II classiﬁcation was employed for the AI lesions. The
ideal revascularization procedure for treating patients depends on
the severity of the lesion: in Type A endovascular procedures are
recommended; in Type D surgery is the treatment of choice. In Types
B and C, endovascular treatment is the preferred treatment for Type B
lesions and surgery is the preferred treatment for good-risk patients
with Type C lesions, but the patient’s co-morbidities, fully informed
patient’s preference and the local operator’s long-term success rate
must be considered when making treatment recommendations for
Type B and Type C lesions. 8
Treatment of aortic aneurysms depends on the risk of rupture that
is still primarily based on the maximum aneurysm diameter, with
some allowance made for factors that modify rupture risk, such as
gender and current smoking, 19 and on individual patient features.
Endovascular aneurysm repair (EVAR) has proven to be an effective
modality for treating abdominal aortic aneurysms, particularly in
patients with renal disease; its several advantages over the standard
open procedure include lower morbidity, shorter operative time,
and shorter hospital stay. 6 In our series, 3 EVAR procedures
were performed without any complication or any changes in graft
survival. The survival of the graft was 100% and the postoperative
complications were two hematomas and one occlusion of a branch
during follow-up (4–30 months, mean 14 month), comparable with
the results of Galazka et al. where, after vascular reconstruction and
kidney transplantation, no patients developed signs of arterial graft
infection. In the postoperative period, there were no vascular graft-
related complications, except for DGF in 50% of cases. 20
5. Conclusions
In conclusion, a vascular imaging study of the AI district should be
performed in patients with risk factors for atherosclerosis who are
on the waiting list for kidney transplantation. In our experience,
CT angiograms were demonstrated to be useful for identifying both
stenotic and dilatative lesions, facilitating the choice of best treatment
and timing. Asymptomatic AI stenoses can be treated simultaneously
with the kidney transplant. This timing implies a reduction of re-
operation surgical risk and allows for the best graft inﬂow. Both symp-
tomatic stenoses and dilatative AI lesions (>5 cm in diameter) should
be treated before transplant because of the risk of complications
arising while on the waiting list. EVAR before transplant reduces risk
of rupture, not compromising the integrity of retroperitoneal tissue
and vascular axis integrity. EVAR can be considered a safe procedure
and it does not compromise arterial graft anastomoses or graft
survival. It should be proposed in high-specialization centers with
low complication incidence and with competence in management of
endovascular treatment complications.
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